evaluate survival complications combined proton photon radiotherapy patients incompletely resected recurrent benign meningioma methods materials NUMBER november NUMBER NUMBER patients partially resected biopsied recurrent meningiomas median age NUMBER years range years treated combined photon proton beam therapy massachusetts general hospital mgh harvard cyclotron laboratory using computed conformal 3d treatment planning patients treated incomplete tumor resection NUMBER patients tumor biopsy NUMBER patients tumor recurrence following gross total patients progression subtotal patients resection patients classified benign meningioma review slides mgh median dose macroscopic gross tumor volume NUMBER cge range cge cge proton gy x NUMBER rbe median NUMBER months range results overall survival NUMBER NUMBER years NUMBER NUMBER respectively rate NUMBER NUMBER years NUMBER NUMBER respectively survival severe toxicity NUMBER NUMBER NUMBER years patients presented local tumor recurrence NUMBER NUMBER NUMBER months patient developed distant intradural metastasis NUMBER NUMBER months patient died recurrent meningioma NUMBER patients died causes fifth patient died brainstem necrosis NUMBER months patients developed severe toxicity radiotherapy including ophthalmologic NUMBER patients neurologic NUMBER patients otologic NUMBER patients complications patients ophthalmologic toxicity received doses higher allowed optic nerve structures current protocol conclusion combined proton photon radiotherapy effective treatment patients recurrent incompletely resected benign intracranial menigiomas observed toxicity appears currently employed dose constraints toxicity exceed seen patients treated conformal fractionated supervoltage photon radiotherapy recurrence free histologically confirmed NUMBER NUMBER NUMBER mev tomography based NUMBER NUMBER follow NUMBER NUMBER recurrence free long term dose related purpose objective NUMBER NUMBER NUMBER NUMBER